| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/01/2004 | CN1525972A Hetero-bicyclic crf antagonists |
| 09/01/2004 | CN1525968A Compositions for prevention or treatment of hepatopathy |
| 09/01/2004 | CN1525956A Alpha -amino-n-hydroxy-acetamide derivatives |
| 09/01/2004 | CN1525863A Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potential pathogenic gram-positive bacteria |
| 09/01/2004 | CN1525862A Novel receptors for dollar i(helicobacter pylori) and use thereof |
| 09/01/2004 | CN1525858A A pharmaceutical composition comprising a nicotinic receptor partial antagonist and an antiemetic agent for modulating cholinergic function |
| 09/01/2004 | CN1524947A Wine and its preparing method |
| 09/01/2004 | CN1524865A Crystalline forms of adefovir dipivoxil ester |
| 09/01/2004 | CN1524583A Use of gene for expressing Notch-ligand in production of medicinal preparations for immunotherapy |
| 09/01/2004 | CN1524577A Alkaline fibroblast growth factor pellicle and its production method |
| 09/01/2004 | CN1524576A Composite thymus peptide with immunoregulation function |
| 09/01/2004 | CN1524571A A medicament and its preparation process |
| 09/01/2004 | CN1524564A Capsule for curing enteritis and bloody flux |
| 09/01/2004 | CN1524552A Chinese medicine preparation for treating fatty liver |
| 09/01/2004 | CN1524550A Traditional Chinese medicine for treating pancreatitis |
| 09/01/2004 | CN1524549A Chinese-medicine oral cavity cleaning aerosol and its preparing process |
| 09/01/2004 | CN1524547A Detoxication method for plant trotter |
| 09/01/2004 | CN1524546A Composition containing radix notoginseng, eucommia and american ginseng |
| 09/01/2004 | CN1524540A Chinese medicine preparation for treating fatty liver and its preparation method |
| 09/01/2004 | CN1524535A Nanometer medicine for treating gastritis and gastric ulcer |
| 09/01/2004 | CN1524527A Piperidine derivatives useful as CCR5 antagonists |
| 09/01/2004 | CN1524519A Lysine hydrochloride powder and injection preparation |
| 09/01/2004 | CN1524518A Use of 2-amino-2(2-(4-octyl phenyl)ethyl)-1,3-propylene glycol in the preparation of medicaments of preventing and curing immune liver injury |
| 09/01/2004 | CN1164616C Recombinant hepatitis B virus immune globulin |
| 09/01/2004 | CN1164574C Phenoxypropylamine compounds |
| 09/01/2004 | CN1164334C Sustained release formulation of peptide |
| 09/01/2004 | CN1164331C Human hepatitis B nucleic acid vaccine |
| 09/01/2004 | CN1164326C Deoxidation type glutathione lozenge |
| 09/01/2004 | CN1164322C Relieving distension and fullness and regulating stomach capsule and its preparation method |
| 09/01/2004 | CN1164314C Achillea total flavone capsule |
| 09/01/2004 | CN1164312C Solid antitussive ointment and preparation method thereof |
| 09/01/2004 | CN1164305C Medicinal powder for curing laryngopharyngitis and ulcerations of the oral cavity |
| 09/01/2004 | CN1164301C Pseudo-ginseng instant powder and its preparation method |
| 09/01/2004 | CN1164295C Application of agave |
| 09/01/2004 | CN1164289C Compound gingko leaf preparation and its making process |
| 09/01/2004 | CN1164274C Nutritive medicine for remitting or treating pregnant woman's vomiting |
| 09/01/2004 | CN1164269C Silybin injection containing cyclo dextrin or its derivatives |
| 09/01/2004 | CN1164189C Making process of china woodfrog oil tea |
| 08/31/2004 | US6784254 Preventing reabsorption of bile acids from the intestine, decreasing lipoprotein cholesterol in the bloodstream, by oral administrating a sequester agent, crosslinked polyallylamine; better taste |
| 08/31/2004 | US6784208 Method for preventing and treating visceral pain and gastrointestinal disorders |
| 08/31/2004 | US6784202 Cubane derivatives as metabotropic glutamate receptor agonists or antagonists and process for their preparation |
| 08/31/2004 | US6784195 Extracellular signal regulated kinase (erk); anticancer agents and protein kinase inhibitors |
| 08/31/2004 | US6784188 Urea substituted imidazoquinolines |
| 08/31/2004 | US6784187 8-carboxamido-2,6-methano-3-benzazocines |
| 08/31/2004 | US6784181 Ligands for the delta receptor |
| 08/31/2004 | US6784179 Tetracyclic derivatives, process of preparation and use |
| 08/31/2004 | US6784174 Inhibitors of the production of cytokines such as tnf |
| 08/31/2004 | US6784169 Metalloprotease inhibitor; antiinflamamtory agents; rheumatic disorders; cardiovascular disorders; controlling cell proliferation |
| 08/31/2004 | US6784166 For the treatment of diseases mediated by the hepatitis c virus |
| 08/31/2004 | US6783780 Nutritional supplement for the prevention and/or treatment of disorders of the digestive tract, which comprises probiotics comprising a lactic acid bacterial strain and a yeast strain of a saccharomyces species and non-digestable oligosaccharides |
| 08/27/2004 | CA2458001A1 Regulation of immune responses by manipulation of intermediary metabolite levels |
| 08/26/2004 | WO2004072643A2 Diagnostics and therapeutics for diseases associated with glucagon-like peptide 2 receptor (glp2r) |
| 08/26/2004 | WO2004072061A1 Method of stabilizing lansoprazole |
| 08/26/2004 | WO2004072016A1 Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| 08/26/2004 | WO2004071520A1 Bifidobacterium preparation for improving immune functions |
| 08/26/2004 | WO2004071511A1 Use of cci-779 in treatment of hepatic fibrosis |
| 08/26/2004 | WO2004071503A1 Remedy for viral disease |
| 08/26/2004 | WO2004071392A2 Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4) |
| 08/26/2004 | WO2004071391A2 Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders |
| 08/26/2004 | WO2004071381A2 Drugs containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds |
| 08/26/2004 | WO2004071378A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 08/26/2004 | WO2003070911A3 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r) |
| 08/26/2004 | WO2003055440A3 Compositions and methods for the treatement of immune related diseases |
| 08/26/2004 | WO2001051003A3 Use of lipid conjugates in the treatment of disease |
| 08/26/2004 | US20040167341 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 08/26/2004 | US20040167336 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine |
| 08/26/2004 | US20040167176 Tricyclic compounds useful as angiotensin II agonists |
| 08/26/2004 | US20040167174 Substituted acylhydroxamic acids and method of reducing TNFalpha levels |
| 08/26/2004 | US20040167154 Urea substituted imidazoquinolines |
| 08/26/2004 | US20040167149 Aryl fused azapolycyclic compounds |
| 08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 08/26/2004 | US20040167137 Xanthine phosphodiesterase V inhibitors |
| 08/26/2004 | US20040167135 Dihydropyrimidines |
| 08/26/2004 | US20040167133 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/26/2004 | US20040167118 Novel diarylalkene derivatives and novel diarylalkane derivatives |
| 08/26/2004 | US20040167092 Medicaments |
| 08/26/2004 | US20040167089 Immunostimulatory nucleic acid molecules |
| 08/26/2004 | US20040167074 Therapeutic applications of mFLINT polypeptides |
| 08/26/2004 | US20040167062 such as anxiety disorder, attention deficit/hyperactivity disorder, autistic disorder, bipolar disorder, major depression, mood disorder, pervasive developmental disorder, psychotic disorder and schizophrenia by administering an antimicrobial composition optionally with a probiotic mixture |
| 08/26/2004 | US20040167034 Emulsion and dispersion formulations and method |
| 08/26/2004 | US20040166171 Antiulcer agents; anaerobic infections |
| 08/26/2004 | DE10306202A1 2-(hetero)aryl-2-(N-((hetero)aryl)-amino)-acetic acid derivatives useful e.g. for treating anxiety, inflammation, allergy, depression, diarrhea or especially pain is NMDA antagonist |
| 08/26/2004 | CA2640585A1 Synthesis of 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspirol{4,4}-non-ene-4-one |
| 08/26/2004 | CA2515676A1 Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders |
| 08/26/2004 | CA2515130A1 Method of stabilizing lansoprazole |
| 08/25/2004 | EP1449843A1 Intermediates for the preparation of carbamoyl tetrahydropyridine derivatives |
| 08/25/2004 | EP1449539A2 Prophylactic or therapeutic use of a Fas antagonist to inhibit Fas-mediated apoptosis |
| 08/25/2004 | EP1449534A1 Matrix metalloprotease inhibitor |
| 08/25/2004 | EP1448995A1 Assay for screening candidate drugs for the treatment of inflammatory diseases |
| 08/25/2004 | EP1448790A2 Methods and compositions for treating cancer |
| 08/25/2004 | EP1448602A2 Modified anti-tnf alpha antibody |
| 08/25/2004 | EP1448583A2 A novel g protein-coupled receptor, gave8 |
| 08/25/2004 | EP1448566A2 Chemokine receptor antagonists and methods of use thereof |
| 08/25/2004 | EP1448564A2 Substituted indolizine-like compounds and methods of use |
| 08/25/2004 | EP1448557A2 Heteroindanes: a new class of potent cannabimimetic ligands |
| 08/25/2004 | EP1448550A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 08/25/2004 | EP1448548A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448546A1 Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake |
| 08/25/2004 | EP1448545A1 Nf-kb inhibitors |
| 08/25/2004 | EP1448544A1 Substituted benzopyrans as selective estrogen receptor-beta agonists |